NASDAQ · Medical - Instruments & Supplies
Innovative Eyewear, Inc. (LUCY) Stock
$0.90
+0.71%
NASDAQ: LUCY
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Innovative Eyewear Launches Claude AI Integration for Lucyd Smart Eyewear
InvestorsHub · Jul 10, 2026
Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear
PR Newswire · Jul 10, 2026
Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds
PR Newswire · Jul 8, 2026
Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group
PR Newswire · Jul 7, 2026
BC-Most Active Stocks
Associated Press · Jul 6, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held7.60%
Institutions Held9.03%
Institutions Float Held9.77%
Peer Comparison
About Innovative Eyewear, Inc.
Innovative Eyewear, Inc. is led by CEO Harrison Reed Gross, employs 11 people, headquartered in US, publicly traded since 2022.
Innovative Eyewear, Inc. (LUCY) stock trades at $0.90 with a market capitalization of $5.69M. The stock is valued at a price-to-earnings (P/E) ratio of -0.66, price-to-book of 0.83, price-to-sales of 1.65. Over the past 52 weeks the stock has ranged between $0.65 and $2.05, and currently trades 56.1% below its 52-week high.
On profitability, Innovative Eyewear, Inc. generates a return on equity (ROE) of -88.90%, return on capital employed of -122.96%, an operating margin of -266.67%, a net profit margin of -225.28%.